المؤلفون: Khoshkhabar R; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran., Yazdani M; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran., Hoda Alavizadeh S; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Alavizadehh@mums.ac.ir., Saberi Z; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran., Arabi L; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran., Reza Jaafari M; Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Jafarimr@mums.ac.ir.

المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Aug 20; Vol. 137, pp. 112437. Date of Electronic Publication: 2024 Jun 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Indoleamine-Pyrrole 2,3,-Dioxygenase*/antagonists & inhibitors , Indoleamine-Pyrrole 2,3,-Dioxygenase*/metabolism , Docetaxel*/pharmacology , Docetaxel*/therapeutic use , Tumor Microenvironment*/drug effects , Tumor Microenvironment*/immunology , Liposomes* , Melanoma, Experimental*/drug therapy , Melanoma, Experimental*/immunology , Sulfonamides*/pharmacology , Sulfonamides*/administration & dosage , Sulfonamides*/therapeutic use , Mice, Inbred C57BL*, Animals ; Mice ; Cell Line, Tumor ; Immunotherapy/methods ; Oximes/pharmacology ; Oximes/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Humans ; Female ; Nanoparticles ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use

المؤلفون: Zhao Q; Inner Mongolia Key Laboratory of Disease-Related Biomarkers, The Second Affiliated Hospital, Baotou Medical College, Baotou 014030, China; School of Basic Medicine, Baotou Medical College, Baotou 014040, China., Yu H; Translational Medicine Center, Baotou Medical College, Baotou 014040, China., Shi M; School of Basic Medicine, Baotou Medical College, Baotou 014040, China., Wang X; School of Basic Medicine, Baotou Medical College, Baotou 014040, China., Fan Z; Inner Mongolia Key Laboratory of Disease-Related Biomarkers, The Second Affiliated Hospital, Baotou Medical College, Baotou 014030, China., Wang Z; Inner Mongolia Key Laboratory of Disease-Related Biomarkers, The Second Affiliated Hospital, Baotou Medical College, Baotou 014030, China. Electronic address: wang.zhanli@hotmail.com.

المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Aug 20; Vol. 137, pp. 112433. Date of Electronic Publication: 2024 Jun 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/genetics , Stomach Neoplasms*/pathology , Stomach Neoplasms*/metabolism , Stomach Neoplasms*/immunology , Ferroptosis*/genetics , Tumor Microenvironment*/immunology , Tumor Microenvironment*/genetics , Lipid Metabolism*/genetics, Humans ; Prognosis ; Gene Expression Regulation, Neoplastic ; Endothelial-Mesenchymal Transition ; Metabolic Reprogramming

المؤلفون: Chen D; Department of Urology, Beijing Chaoyang Hospital Affiliated Capital Medical University, 8 Gong Ti Nan Road, Chaoyang District, Beijing, 100020, China.; Department of Urology, Qilu Hospital of Shandong University, Wenhuaxi Road #107, Jinan, 250012, China., Cao H; Department of Urology, Beijing Chaoyang Hospital Affiliated Capital Medical University, 8 Gong Ti Nan Road, Chaoyang District, Beijing, 100020, China., Zheng X; Department of Urology, Beijing Chaoyang Hospital Affiliated Capital Medical University, 8 Gong Ti Nan Road, Chaoyang District, Beijing, 100020, China., Wang H; Department of Urology, Beijing Chaoyang Hospital Affiliated Capital Medical University, 8 Gong Ti Nan Road, Chaoyang District, Beijing, 100020, China., Han Z; Department of Urology, The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine, NO.1 Jingba Road, Shizhong District, Jinan, 250001, China. hzc3203@163.com., Wang W; Department of Urology, Beijing Chaoyang Hospital Affiliated Capital Medical University, 8 Gong Ti Nan Road, Chaoyang District, Beijing, 100020, China. weiwang0920@163.com.

المصدر: BMC cancer [BMC Cancer] 2024 Aug 19; Vol. 24 (1), pp. 1024. Date of Electronic Publication: 2024 Aug 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/genetics , Urinary Bladder Neoplasms*/immunology , Urinary Bladder Neoplasms*/therapy , Urinary Bladder Neoplasms*/drug therapy , Urinary Bladder Neoplasms*/pathology , Tumor Microenvironment*/immunology , Tumor Microenvironment*/genetics, Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Proteins/genetics ; Immune Checkpoint Proteins/metabolism ; Biomarkers, Tumor/genetics ; Male ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Prognosis ; Transcriptome ; Immunotherapy/methods ; Middle Aged ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Aged

المؤلفون: Yang J; Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China., Li J; Shanxi Medical University, Taiyuan, 030001, China., Li S; Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China., Yang Y; Shanxi Medical University, Taiyuan, 030001, China., Su H; Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China., Guo H; Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China., Lei J; Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China., Wang Y; Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China., Wen K; Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China., Li X; Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China., Zhang S; Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China. zsyprofessor@sxmu.edu.cn., Wang Z; Department of Gynecology, First Hospital of Shanxi Medical University, Taiyuan, 030001, China. wangzhe@sxmu.edu.cn.

المصدر: Molecular biomedicine [Mol Biomed] 2024 Aug 14; Vol. 5 (1), pp. 32. Date of Electronic Publication: 2024 Aug 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer Singapore Country of Publication: Singapore NLM ID: 9918283581406676 Publication Model: Electronic Cited Medium: Internet ISSN: 2662-8651 (Electronic) Linking ISSN: 26628651 NLM ISO Abbreviation: Mol Biomed Subsets: MEDLINE

مواضيع طبية MeSH: Endometrial Neoplasms*/genetics , Endometrial Neoplasms*/immunology , Endometrial Neoplasms*/pathology , Tumor Microenvironment*/immunology , Tumor Microenvironment*/genetics , Gene Expression Regulation, Neoplastic*, Humans ; Female ; Prognosis ; Homeodomain Proteins/genetics ; Homeodomain Proteins/metabolism ; Transcriptome ; Genes, Homeobox/genetics ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Databases, Genetic ; Gene Expression Profiling ; Middle Aged

المؤلفون: Körner M; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany., Spohn M; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Bioinformatics Core, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schüller U; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Bockmayr M; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; bAIome - Center for Biomedical AI, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

المصدر: Oncoimmunology [Oncoimmunology] 2024 Aug 09; Vol. 13 (1), pp. 2386789. Date of Electronic Publication: 2024 Aug 09 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment*/immunology , Tumor Microenvironment*/genetics , Glioma*/genetics , Glioma*/immunology , Glioma*/pathology , Brain Neoplasms*/genetics , Brain Neoplasms*/pathology , Brain Neoplasms*/immunology, Humans ; Child ; Female ; Male ; Neoplasm Grading ; Gene Expression Profiling ; Transcriptome ; Child, Preschool ; Adolescent ; Stromal Cells/pathology ; Stromal Cells/metabolism ; Stromal Cells/immunology

المؤلفون: Xu L; Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China., Liu J; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China., An Y; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China., Zhou L; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China., Sun H; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China., Xu Z; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China., Wang D; Department of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212001, China., Liang Z; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China., Xu C; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China. caihuaxu@suda.edu.cn., Wang B; Department of Oncology, Changshu No.1 People's Hospital, Suzhou, 215500, China. wby0113@suda.edu.cn., Li W; Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China. liwei10@suda.edu.cn.

المصدر: BMC cancer [BMC Cancer] 2024 Aug 08; Vol. 24 (1), pp. 979. Date of Electronic Publication: 2024 Aug 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Stomach Neoplasms*/genetics , Stomach Neoplasms*/immunology , Stomach Neoplasms*/pathology , Stomach Neoplasms*/mortality , Tumor Microenvironment*/immunology , Tumor Microenvironment*/genetics , Glycolysis*/genetics, Humans ; Prognosis ; Gene Expression Regulation, Neoplastic ; Male ; Biomarkers, Tumor/genetics ; Female ; Gene Expression Profiling ; Middle Aged ; Adenocarcinoma/genetics ; Adenocarcinoma/immunology ; Adenocarcinoma/pathology ; Cell Line, Tumor

المؤلفون: Xu-Monette ZY; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Luo C; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Yu L; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Li Y; Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Bhagat G; Department of Pathology and Cell Biology, Columbia University Irving Medical Center and New York Presbyterian Hospital, New York, NY, USA., Tzankov A; Institute of Pathology, University Hospital Basel, Basel, Switzerland., Visco C; Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy., Fan X; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Dybkaer K; Clinical Department, Aalborg University Hospital, Aalborg, Denmark., Sakhdari A; Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada., Wang NT; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Yuan AF; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Chiu A; Hematopathology Department, Mayo Clinic, Rochester, MN, USA., Tam W; Department of Pathology, Northwell Health, New York, NY, USA., Zu Y; Department of Pathology and Genomic Medicine, The Methodist Hospital, Houston, TX, USA., Hsi ED; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Perry AM; Department of Pathology, University of Michigan, Ann Arbor, MI, USA., Song W; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., O'Malley D; NeoGenomics Laboratories, Aliso Viejo, CA, USA., Au Q; NeoGenomics Laboratories, Aliso Viejo, CA, USA., Nunns H; NeoGenomics Laboratories, Aliso Viejo, CA, USA., Go H; Department of Pathology, Asan Medical Center, Ulsan University College of Medicine, Seoul, South Korea., Møller MB; Department of Pathology, Odense University Hospital, Odense, Denmark., Parsons BM; Hematology & Oncology, Gundersen Lutheran Health System, La Crosse, WI, USA., Montes-Moreno S; Translational Hematopathology Laboratory and Anatomic Pathology Service, Valdecilla/IDIVAL, UNICAN, Santander, Spain., Ponzoni M; Pathology Unit, Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Ferreri AJM; Pathology Unit, Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Sohani AR; Massachusetts General Hospital, Center for Lymphoma, Harvard Medical School, Boston, MA, USA., Abramson JS; Massachusetts General Hospital, Center for Lymphoma, Harvard Medical School, Boston, MA, USA., Xu B; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA., Young KH; Hematopathology Division and Department of Pathology, Duke University Medical Center, Durham, NC, USA.; Duke Cancer Institute, Durham, NC, USA.

المصدر: Oncoimmunology [Oncoimmunology] 2024 Aug 05; Vol. 13 (1), pp. 2384667. Date of Electronic Publication: 2024 Aug 05 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/genetics , Lymphoma, Large B-Cell, Diffuse*/immunology , Lymphoma, Large B-Cell, Diffuse*/pathology , DNA Mismatch Repair*/genetics , Tumor Microenvironment*/immunology , Tumor Microenvironment*/genetics, Humans ; Male ; Female ; Mutation ; Middle Aged ; Aged ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Prognosis ; Adult ; Mismatch Repair Endonuclease PMS2/genetics ; Mismatch Repair Endonuclease PMS2/metabolism ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism

المؤلفون: Li X; Department of Pathology, Chongqing Changshou District Maternal and Child Health Hospital, Chongqing, China., Jian J; Department of Pathology, Chongqing Changshou District Maternal and Child Health Hospital, Chongqing, China., Zhang A; Department of Pathology, Jiaxing University Affiliated Women and Children Hospital (Jiaxing Maternity and Child Health Care Hospital), Jiaxing University, Jiaxing, China., Xiang JM; Department of Surgery, Chongqing Changshou District Maternal and Child Health Hospital, Chongqing, China., Huang J; Department of Surgery, Chongqing Changshou District Maternal and Child Health Hospital, Chongqing, China., Chen Y; Department of Pathology, Women and Children's Hospital of Chongqing Medical University (Chongqing Health Center for Women and Children), Chongqing Medical University, Chongqing, China. chenyl_doctor@163.com.

المصدر: Scientific reports [Sci Rep] 2024 Aug 05; Vol. 14 (1), pp. 18125. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment*/immunology , Tumor Microenvironment*/genetics , Thyroid Cancer, Papillary*/genetics , Thyroid Cancer, Papillary*/immunology , Thyroid Cancer, Papillary*/pathology , Thyroid Cancer, Papillary*/therapy , Thyroid Neoplasms*/genetics , Thyroid Neoplasms*/immunology , Thyroid Neoplasms*/pathology , Thyroid Neoplasms*/therapy , Immunotherapy*/methods, Humans ; Prognosis ; Gene Expression Regulation, Neoplastic ; Gene Expression Profiling ; Biomarkers, Tumor/genetics ; Male

المؤلفون: Huang L; Department of Urology, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, Hunan, China., Xie Y; Department of Urology, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, Hunan, China., Jiang S; Department of Urology, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, Hunan, China., Dai T; Department of Urology, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, Hunan, China., Xu Z; Department of Urology, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Hunan Cancer Hospital, Changsha, Hunan, China., Shan H; Department of Emergency Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, Hunan, China. shirleyv5@163.com.

المصدر: Scientific reports [Sci Rep] 2024 Aug 04; Vol. 14 (1), pp. 18036. Date of Electronic Publication: 2024 Aug 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment*/immunology , Tumor Microenvironment*/genetics , Prostatic Neoplasms*/drug therapy , Prostatic Neoplasms*/genetics , Prostatic Neoplasms*/immunology , Prostatic Neoplasms*/pathology , Prostatic Neoplasms*/metabolism , Androgens*/metabolism , Gene Expression Regulation, Neoplastic*/drug effects, Humans ; Male ; Gene Expression Profiling ; Prognosis ; Transcriptome ; Computational Biology/methods

المؤلفون: Liu R; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China., Yang T; Department of Surgery, Xiangya Hospital, Central South University, Changsha, China., Huang J; Department of Oncology, Xiangya Hospital, Central South University, Changsha, China., Xiao Z; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China., Liu J; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China., Li Z; Department of Hepatic biliary pancreatic and spleen surgery, The First Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China. oliverleeee@126.com., Tong S; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China. tongshiyu@csu.edu.cn.

المصدر: BMC cancer [BMC Cancer] 2024 Aug 02; Vol. 24 (1), pp. 947. Date of Electronic Publication: 2024 Aug 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Urinary Bladder Neoplasms*/genetics , Urinary Bladder Neoplasms*/therapy , Urinary Bladder Neoplasms*/immunology , Urinary Bladder Neoplasms*/pathology , Urinary Bladder Neoplasms*/mortality , Tumor Microenvironment*/immunology , Tumor Microenvironment*/genetics , Immunotherapy*/methods , Glycosyltransferases*/genetics , Glycosyltransferases*/metabolism , Phenotype* , Nomograms*, Humans ; Prognosis ; Male ; Female ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Biomarkers, Tumor/genetics ; Middle Aged ; Risk Assessment ; Aged ; Gene Expression Regulation, Neoplastic ; Risk Factors